Found: 10
Select item for more details and to access through your institution.
Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.
- Published in:
- 2012
- By:
- Publication type:
- journal article
P02-132 - Evaluation of psychological impact of facial lipoatrophy in HIV: the “assessment of face & body change and distress” questionnaire
- Published in:
- 2010
- By:
- Publication type:
- Abstract
T20QoL: an observational multicenter cohort study to evaluate the quality of life in HIV-patients treated with enfuvirtide (ENF, T-20) in combination with an optimized background therapy.
- Published in:
- Biologics: Targets & Therapy, 2008, v. 2, n. 3, p. 577
- By:
- Publication type:
- Article
The health equity in all policies (HEiAP) approach before and beyond the Covid-19 pandemic in the Italian context.
- Published in:
- 2020
- By:
- Publication type:
- Letter
The mutational archive in proviral DNA does not change during 24 months of continuous or intermittent highly active antiretroviral therapy.
- Published in:
- HIV Medicine, 2009, v. 10, n. 8, p. 477, doi. 10.1111/j.1468-1293.2009.00715.x
- By:
- Publication type:
- Article
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<LT>50 cells/microL)
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
Original Research Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/mμL)
- Published in:
- HIV Medicine, 2004, v. 5, n. 1, p. 1, doi. 10.1111/j.1468-1293.2004.00177.x
- By:
- Publication type:
- Article
ISSQoL: a new questionnaire for evaluating the quality of life of people living with HIV in the HAART era.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors.
- Published in:
- International Journal of STD & AIDS, 2012, v. 23, n. 7, p. 459, doi. 10.1258/ijsa.2012.011391
- By:
- Publication type:
- Article